Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart

被引:266
|
作者
Heymans, S
Schroen, B
Vermeersch, P
Milting, H
Gao, FY
Kassner, A
Gillijns, H
Herijgers, P
Flameng, W
Carmeliet, P
de Werf, FV
Pinto, YM
Janssens, S
机构
[1] Univ Maastricht, Expt & Mol Cardiol CARIM, Maastricht, Netherlands
[2] Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, Louvain, Belgium
[3] Katholieke Univ Leuven Hosp, Dept Cardiovasc Surg, B-3000 Louvain, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Cardiol, B-3000 Louvain, Belgium
[5] Ruhr Univ Bochum, Univ Klin, Herz & Diabeteszentrum NRW, Erich & Hanna Klessmann Inst Kardiovaskulare Fors, Bad Oeynhausen, Germany
关键词
metalloproteinases; remodeling; hypertrophy; hypertension; collagen;
D O I
10.1161/CIRCULATIONAHA.104.516963
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Alterations in the balance of matrix metalloproteinases ( MMPs) and their specific tissue inhibitors (TIMPs) are involved in left ventricular (LV) remodeling. Whether their expression is related to interstitial fibrosis or LV dysfunction in patients with chronic pressure overload - induced LV hypertrophy, however, is unknown. Methods and Results - Therefore, cardiac biopsies were taken in 36 patients with isolated aortic stenosis ( AS) and in 29 control patients without LV hypertrophy. Microarray analysis revealed significantly increased mRNA expression of collagen types I, III, and IV and transcripts involved in collagen synthesis, including procollagen endopeptidase and lysine and proline hydroxylases, in AS compared with control patients. Collagen deposition was greater in AS than in control patients and was most pronounced in AS patients with severe diastolic dysfunction. Cardiac mRNA expression of TIMP-1 and TIMP-2 was significantly increased in AS compared with control patients ( mRNA transcript levels normalized to GAPDH: TIMP-1, 0.67 +/- 0.1 in AS versus 0.37 +/- 0.08 in control patients; TIMP-2, 9.5 +/- 2.6 in AS versus 1.6 +/- 0.4 in control patients; P < 0.05 for both) but did not differ significantly for MMP-1, -2, or -9. Cardiac TIMP-1 and - 2 transcripts were significantly related to the degree of interstitial fibrosis and proportional to diastolic dysfunction in AS patients. Conclusions - Cardiac expression of TIMP-1 and TIMP-2 is significantly increased in chronic pressure-overloaded human hearts compared with controls and is related to the degree of interstitial fibrosis.
引用
收藏
页码:1136 / 1144
页数:9
相关论文
共 50 条
  • [31] Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
    Zhang, Yongxiang
    Li, Yuechuan
    Ye, Zhen
    Ma, Hui
    MEDICAL SCIENCE MONITOR, 2020, 26 : e925278
  • [32] Subnormal tissue inhibitor of metalloproteinase expression modulates matrix metalloproteinase-2 activity and fibrosis in aortic regurgitation
    Schuleri, K
    Lee, E
    Pitlor, LL
    Truter, SL
    Borer, JS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 431A - 432A
  • [33] Increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary
    Okamoto, T
    Niu, R
    Yamada, S
    MOLECULAR HUMAN REPRODUCTION, 2003, 9 (10) : 569 - 575
  • [34] Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-2 in human endometrial carcinoma
    陈梅
    薄乃秀
    黄亚军
    戴琪
    巩丽梅
    生殖医学杂志, 2010, 19(S2) (S2) : 59 - 63
  • [35] Human cardiac fibroblast extracellular matrix remodeling: dual effects of tissue inhibitor of metalloproteinase-2
    Ngu, Janet M. C.
    Teng, Guoqi
    Meijndert, Hans Christopher
    Mewhort, Holly E.
    Turnbull, Jeannine D.
    Stetler-Stevenson, William G.
    Fedak, Paul W. M.
    CARDIOVASCULAR PATHOLOGY, 2014, 23 (06) : 335 - 343
  • [36] Altered expression of metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in cervical disc herniation patients
    Zhuang, H. M.
    Xu, G. T.
    Wen, S. F.
    Guo, Y. Y.
    Huang, Q.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02):
  • [37] Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium
    Chung, HW
    Lee, JY
    Moon, HS
    Hur, SE
    Park, MH
    Wen, Y
    Polan, ML
    FERTILITY AND STERILITY, 2002, 78 (04) : 787 - 795
  • [38] DIFFERENTIAL MESSENGER-RNA EXPRESSION OF RENAL CORTICAL TISSUE INHIBITOR OF METALLOPROTEINASE-1, METALLOPROTEINASE-2, AND METALLOPROTEINASE-3 IN EXPERIMENTAL HYDRONEPHROSIS
    ENGELMYER, E
    VANGOOR, H
    EDWARDS, DR
    DIAMOND, JR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 5 (09): : 1675 - 1683
  • [40] Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
    Kanayama, H
    Yokota, K
    Kurokawa, Y
    Murakami, Y
    Nishitani, M
    Kagawa, S
    CANCER, 1998, 82 (07) : 1359 - 1366